Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2005-01-24 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LA FERTE MACE (61410), Orne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES ANDAINES : revenue, balance sheet and financial ratios
PHARMACIE DES ANDAINES is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LA FERTE MACE (61410),
this company of category PME
shows in 2024 a revenue of 3.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES ANDAINES (SIREN 480536036)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
3 176 279 €
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
212 434 €
156 202 €
174 101 €
159 543 €
160 701 €
124 158 €
124 801 €
77 032 €
128 628 €
117 745 €
EBITDA
N/C
245 214 €
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
4.9%
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DES ANDAINES generates positive net income of 212 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 118 k€ -> 212 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
212 434 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 40%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
40.296%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
62.954%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES ANDAINES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
238.077
174.474
183.949
140.696
114.485
92.838
80.522
62.572
49.364
40.296
Financial autonomy
27.765
33.924
33.247
39.062
43.294
47.209
50.58
56.985
59.247
62.954
Repayment capacity
None
None
None
None
None
None
None
None
3.688
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
6.295%
None%
Sector positioning
Debt ratio
40.32025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of PHARMACIE DES ANDAINES (40.30) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
62.95%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE DES ANDAINES (63.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
3.69 years2024
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Average
In 2024, the repayment capacity of PHARMACIE DES ANDAINES (3.69) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 231.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
231.937
Liquidity indicators evolution PHARMACIE DES ANDAINES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
309.671
243.126
288.309
268.287
229.171
222.843
273.141
327.123
234.976
231.937
Interest coverage
None
None
None
None
None
None
None
None
3.468
None
Sector positioning
Liquidity ratio
231.942025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good-9 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DES ANDAINES (231.94) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
3.47x2024
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Good
In 2024, the interest coverage of PHARMACIE DES ANDAINES (3.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES ANDAINES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
282 911 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
28
0
Customer payment term (days)
0
0
0
0
0
0
0
0
6
0
Supplier payment term (days)
0
0
0
0
0
0
0
0
35
0
Positioning of PHARMACIE DES ANDAINES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES ANDAINES is estimated at
3 374 539 €
(range 2 289 978€ - 5 295 116€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2289k€3374k€5295k€
3 374 539 €Range: 2 289 978€ - 5 295 116€
NAF 5 année 2025
Valuation method used
Net Income Multiple
212 434 €
×
15.9x
=3 374 539 €
Range: 2 289 978€ - 5 295 117€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES ANDAINES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES ANDAINES
What is the revenue of PHARMACIE DES ANDAINES ?
The revenue of PHARMACIE DES ANDAINES in 2024 is 3.2 M€.
Is PHARMACIE DES ANDAINES profitable?
Yes, PHARMACIE DES ANDAINES generated a net profit of 212 k€ in 2025.
Where is the headquarters of PHARMACIE DES ANDAINES ?
The headquarters of PHARMACIE DES ANDAINES is located in LA FERTE MACE (61410), in the department Orne.
Where to find the tax return of PHARMACIE DES ANDAINES ?
The tax return of PHARMACIE DES ANDAINES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES ANDAINES operate?
PHARMACIE DES ANDAINES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart